Reverse genetics using RNAi in non-mouse mammals
Reverse genetics using RNAi in non-mouse mammals
批准号:
7343224
负责人:
ZUOSHANG XU
金额:
$19.59万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-02-01 至 2009-01-31
关键词:
AgeCloningComplexDNA Polymerase IIDNA Polymerase IIIDevelopmentDiseaseDisease modelEukaryotaEukaryotic CellGene ExpressionGene TargetingGenesGoalsInvestigationKnock-outLengthMammalsMediatingModelingMusOxidative StressPathway interactionsPhenotypeRNARNA InterferenceRattusSequence HomologySmall Interfering RNASubfamily lentivirinaeTechnologyTestingTimeTransgenesTransgenic MiceTransgenic OrganismsWorkage relatedbaseconceptcostgene functionhomologous recombinationin vivoknock-downknockout genepositional cloningpromoterresearch studysmall hairpin RNAsuccess
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
Gene knockout technology in mice has been instrumental in investigating gene functions in mammals. It has been used to reveal gene functions in normal as well as in pathogenic pathways in vivo, and to generate disease models including many age-dependent diseases. However, the technical complexity, the length of time and the high cost of gene knockout approach has limited its wider use. Additionally, the technology is limited to investigations in mice and gene knockouts in other mammalian species can only be done with cloning, which is technically even more complex, difficulty and expensive than gene knockout by homologous recombination. RNA interference (RNAi) can mediate sequence-selective suppression of gene expression in a wide variety of eukaryotes by introducing short RNA duplexes (called small interfering RNAs or siRNAs) with sequence homologies to the target gene or short hairpin RNAs (shRNAs) synthesized from a Pol III or Pol II promoters. Our recent experiments have demonstrated that shRNA expressed by Pol II can silence target gene expression to the extent that knockout phenotypes are observed in transgenic mice. Based on our success in mice, we propose to investigate the potential for this technology to be used in reverse genetics in other mammalian species, using rat as a model. Our RNAi strategy uses Pol II synthesized shRNA. Our goal is to establish the concept that the reverse genetics can be done using RNAi in mammalian species other than the mouse. We propose to (1) make and test the transgene construct against the rat sod2 gene based on lentivirus delivery technology and (2) generate and analyze the transgenic rat and determine whether the RNAi strategy can knock down the rat sod2 gene and produce phenotypes expected of sod2 gene deficiency, as observed in mice. If successful, this work will produce a new rat model in oxidative stress and aging, and importantly, establish the concept that RNAi technology can be used to investigate gene functions and create disease models in rat and non-mouse mammalian species.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Protein Arginine Deiminase 2 (PAD2) and Protein Citrullination in ALS
-
批准号:10399654
-
项目类别:
-
资助金额:$48.77万
-
财政年份:2021
-
负责人:ZUOSHANG XU
-
依托单位:
Protein Arginine Deiminase 2 (PAD2) and Protein Citrullination in ALS
-
批准号:10605239
-
项目类别:
-
资助金额:$48.77万
-
财政年份:2021
-
负责人:ZUOSHANG XU
-
依托单位:
Protein Arginine Deiminase 2 (PAD2) and Protein Citrullination in ALS
-
批准号:10298171
-
项目类别:
-
资助金额:$48.77万
-
财政年份:2021
-
负责人:ZUOSHANG XU
-
依托单位:
A new approach to immunotherapy for ALS
-
批准号:9808031
-
项目类别:
-
资助金额:$46.06万
-
财政年份:2019
-
负责人:ZUOSHANG XU
-
依托单位:
An in vivo approach to understanding mutant PFN1 toxicity on motor neurons
-
批准号:9893934
-
项目类别:
-
资助金额:$36.64万
-
财政年份:2017
-
负责人:ZUOSHANG XU
-
依托单位:
A new approach to modeling ALS based on TBK1 mutation in mice
-
批准号:9275555
-
项目类别:
-
资助金额:$20.94万
-
财政年份:2016
-
负责人:ZUOSHANG XU
-
依托单位:
Does TDP-43 dysfunction in astrocytes trigger motor neuron degeneration?
-
批准号:9110354
-
项目类别:
-
资助金额:$25.13万
-
财政年份:2015
-
负责人:ZUOSHANG XU
-
依托单位:
Modeling Mutant Profilin 1 Toxicity and ALS in vivo
-
批准号:8490556
-
项目类别:
-
资助金额:$20.8万
-
财政年份:2013
-
负责人:ZUOSHANG XU
-
依托单位:
Transgenic models of ALS caused by VAPB mutation
-
批准号:8055338
-
项目类别:
-
资助金额:$34.84万
-
财政年份:2008
-
负责人:ZUOSHANG XU
-
依托单位:
Transgenic models of ALS caused by VAPB mutation
-
批准号:7567500
-
项目类别:
-
资助金额:$35.55万
-
财政年份:2008
-
负责人:ZUOSHANG XU
-
依托单位:
Transgenic models of ALS caused by VAPB mutation
-
批准号:7799908
-
项目类别:
-
资助金额:$35.19万
-
财政年份:2008
-
负责人:ZUOSHANG XU
-
依托单位:
Transgenic models of ALS caused by VAPB mutation
-
批准号:8265853
-
项目类别:
-
资助金额:$34.84万
-
财政年份:2008
-
负责人:ZUOSHANG XU
-
依托单位:
Transgenic models of ALS caused by VAPB mutation
-
批准号:7466543
-
项目类别:
-
资助金额:$35.55万
-
财政年份:2008
-
负责人:ZUOSHANG XU
-
依托单位:
Modeling TDP-43 Dysfunction in vivo
-
批准号:7451906
-
项目类别:
-
资助金额:$17.77万
-
财政年份:2008
-
负责人:ZUOSHANG XU
-
依托单位:
Understanding CLIM2 functions in vivo using transgenic RNAi
-
批准号:7472089
-
项目类别:
-
资助金额:$20.43万
-
财政年份:2008
-
负责人:ZUOSHANG XU
-
依托单位:
Modeling Progranulin hypomorphism for FTD in mice
-
批准号:7362633
-
项目类别:
-
资助金额:$17.77万
-
财政年份:2007
-
负责人:ZUOSHANG XU
-
依托单位:
Modeling Progranulin hypomorphism for FTD in mice
-
批准号:7495557
-
项目类别:
-
资助金额:$21.33万
-
财政年份:2007
-
负责人:ZUOSHANG XU
-
依托单位:
Silencing mutant SOD1 in vivo for treatment of ALS
-
批准号:7247798
-
项目类别:
-
资助金额:$22.82万
-
财政年份:2007
-
负责人:ZUOSHANG XU
-
依托单位:
Reverse genetics using RNAi in non-mouse mammals
-
批准号:7212491
-
项目类别:
-
资助金额:$16.66万
-
财政年份:2007
-
负责人:ZUOSHANG XU
-
依托单位:
Silencing mutant SOD1 in vivo for treatment of ALS
-
批准号:7385006
-
项目类别:
-
资助金额:$17.84万
-
财政年份:2007
-
负责人:ZUOSHANG XU
-
依托单位:
海外基金